Introduction
While the interaction between T cells and MHC-peptide complexes in the presence of co-stimulatory molecules on the surface of APCs induces T cell activation, the interaction in the absence of co-stimulatory molecules induces T cell unresponsiveness. The latter seems to account for the peripheral self tolerance of tissue-specific antigens (Guerder and Flavell, 1995) . Based on this knowledge, soluble antigen presenting molecules such as MHC molecules either extracted from cell membranes, which were subjected to peptide elution following exchange for specific peptides in vitro (Spacket et al., 1995; Sharma et al., 1991; Nag et al., 1996) , or recombinant MHC molecules loaded with peptides in vitro (Godeau et al., 1992; Scheirle et al., 1992; Stern et al., 1992; Abastado et al., 1995; Altman et al., 1996; Scott et al., 1996) , or genetically engineered, covalently-linked peptide-MHC chimeras (Dal Porto et al., 1993; Kozono et al., 1994; Mottez et al., 1995; Femont et al., 1996; Rhode et al., 1996) , became a novel platform to designing prodrugs with potential immunomodula-tory effects. However, because self peptides bound to the MHC groove exhibit very low off rates (Buus et al., 1987; Tampe and McConnell, 1991) , it is difficult to generate in vitro homogenous populations of MHC-peptide complexes of therapeutic use.
The drawback of monovalent recombinant MHC-peptide molecules lacking the membrane anchoring motifs is their low intrinsic affinity for the cognate TCRs (Weber et al., 1992; Corr et al., 1994; Matsui et al., 1994; Sykulev et al., 1994) . Generating dimeric MHC-peptide complexes was expected to prevail over this inconvenience. Indeed, the human (HLA)-A2 heavy chain expressing the BirA-dependent biotinylation site at the carboxy end was tetramerized by streptavidin and used successfully to phenotype low frequency HIV-specific T cells in the blood of HIV-infected individuals (Altman et al., 1996) . A similar approach showed that soluble dimerized MHC class Ipeptide complexes by a polyclonal anti-class I antibody, but not the monomers, were able to bind with high affinity to the antigen-specific T cells . Although such non-covalently multimerized MHC-peptide complexes exhibit high affinity binding to the cognate TCRs, their stability in vivo remains to be investigated.
Herein we describe a novel MHC class II antigen presenting molecule HA110-120-I-E d αβ-Fcγ2a, designated as DEF. The recombinant DEF consists in a disulfide stabilized I-E d αβ molecule expressing the immunodominant CD4 T helper epitope of HA of the A/PR/8/34 influenza virus, which is dimerized via the Fc portion of IgG2a. This molecule preserved the structural integrity and functions of both MHC-peptide complex and immunoglobulin (Ig) counterparts, and it was able to trigger early signal transduction events in T cells following interaction with the cognate TCR.
Materials and methods

Mice
Transgenic BALB/c mice expressing the 14.3d TCR specific for HA110-120 peptide in association with I-E d class II molecules were used as source of HA110-120-specific T cells. BALB/c mice seven to eight weeks old were purchased from Jackson Laboratories, USA.
Purification of transgenic T cells
The T cells were purified from the spleens of transgenic mice by Ficoll-Hypaque gradient centrifugation, followed by enrichment on nylon wool Unisorb T&B columns (Nycomed, Oslo, Norway) as previously described . T cells were enriched to 85% according to FACS analysis by using 2C11 mAb anti-CD3-FITC conjugate. This preparation contained 32% TCR-HA transgenic T cells according to FACS analysis using 6.5.2 anti-TCR clonotypic mAb.
Genetic construction of DEF chimeric molecule
The genes encoding the I-E d β and Ig-Fcγ2a chain fragments were obtained by RT-PCR from total RNA isolated from 2PK3 B lymphoma cell line (ATCC) and 14-4-4 hybridoma 
Protein production and purification
The baculovirus/insect cells system was used to generate the HA110-120-I-E d αβ-Fcγ2a dimeric molecule (DEF). Recombinant baculoviruses were obtained by cotransfection of linear AcMNPV DNA and DEF-p2Bac vector in SF9 insect cells following the manufacturer's instructions (InVitrogen). Scale production was obtained by infection of SF9 cells with 10 p.f.u./cell of recombinant baculovirus. Supernatants were monitored daily for the protein secretion by a sandwich radioimmunoassay (RIA) according to a previously described protocol . Screening and titration of recombinant viruses were done by detection of protein production in the cell culture supernatants. Briefly, supernatants (50 µl) were incubated for 24 h at 4°C in microtiter plates coated with goat anti-γ2a Abs (5 µg/ml), plates blocked for 2 h at room temperature with PBS/BSA 3%, and captured DEF molecules were revealed with 125 I-goat anti-γ2a Abs (5ϫ10 4 c.p.m./well). After washing with Tween 20 (0.05%) in PBS, bound radiolabeled goat anti-γ2a Abs were measured in a γ-counter (Pharmacia, LKB). The amount of DEF in culture supernatants was estimated by using a standard curve constructed with 14-4-4 mAb (IgG2a). The maximum secretion of 4-4.5 mg/L was obtained 4-5 days post-infection. Cell culture supernatants containing DEF molecules were adjusted to pH 7.5, treated with a cocktail of protease inhibitors (Complete TM protease inhibitor cocktail tablets, Boehringer Mannheim) and passed through a goat anti-γ2a-Sepharose column. The eluted material was collected on 1 M Tris-HCl, pH 8, dialyzed against PBS, and concentrated on Carbowax 20 000 Da (Sigma Chemicals) in dialysis bags of 1000 Da MWCO (Spectrapor). The eventual aggregated material was removed by ultracentrifugation and the protein concentration was estimated by RIA as described.
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Chromatographic characterization
To analyze the molecular size of the affinity purified DEF molecule, a Superose 6 column (30ϫ1cm, Pharmacia, LKB) was first equilibrated with 0.1 M ammonium bicarbonate, pH 8.0 and a mixture of MW standard proteins-mouse IgG, chicken-egg ovalbumin and cytochrome c-was applied in the column at 1 ml/min flow rate. After standardization, 100 µg DEF in 200 µl PBS was applied in the column under identical running conditions, and the elution time of the peak fractions was plotted against the elution time of the MW standard proteins. Fractions were also analyzed individually for the presence of DEF molecule by SDS-PAGE and Western blot.
To analyze the degree of glycosylation by SF9 insect cells, affinity purified DEF was chromatographed on a MONO Q anion exchange column (5/30 HR, Pharmacia, LKB). The column was equilibrated with 20 mM Tris-HCl, pH 7.5 and 100 µg DEF in 200 µl equilibrating buffer was applied at 1 ml/min flow rate over 30 min gradient from 0 to 0.5 M NaCl. Fractions were collected at 1 min intervals, the peak fractions were pooled together and analyzed for the presence of DEF molecule by SDS-PAGE and Western blot. SDS-PAGE and Western blot analyses SDS-PAGE was performed in 4-12% gradient gels (Bio-Rad) according to the manufacturer's instructions. Briefly, 5 µg of the affinity purified DEF were incubated either at room temperature, or boiled in 0.1% Tris-HCl/SDS for 5 min in the presence or absence of β-mercaptoethanol (2-ME) reducing agent. Samples were electrophoresed for 45 min at 150 V, and the gels were either silver stained or electrotransfered in semidry conditions for 45 min at 200 mA/gel onto PVDF membranes (0.2 µ). Membranes were blocked overnight at 4°C with 5% free-fat milk (Carnation) in PBS, incubated for 2 h at room temperature with 125 I-goat anti-mouse γ2a Ab or 125 I-14-4-4 mAb in 1% PBS/BSA at 10 7 c.p.m./membrane, then washed extensively with 0.05% Tween 20 in PBS, and exposed overnight on Kodak X-OMAT films at -80°C.
FACS analyses
Purified transgenic T cells (1ϫ10 6 ) or 14-3-1 T cell hybridoma (TcH) expressing the 14.3d TCR specific for I-E d class II/ HA110-120 peptide complex (Kirberg et al., 1994) were incubated in 100 µl 1% PBS/BSA for 30 min on ice, with 10 µg/ml purified DEF in the presence or absence of 100 µg/ ml 6.5.2 anti-TCR clonotypic mAb (Weber et al., 1992) . Cells were washed in cold 1% PBS/BSA/0.1% NaN 3 , and bound DEF molecules were labeled with goat anti-γ2a-FITC conjugate (Boehringer Mannheim) for 30 min on ice. As a control for non-specific fluorescence, cells were incubated only with goat anti-γ2a-FITC conjugate. The percentage of transgenic T cells expressing the specific TCR was estimated to 32% by staining with 6.5.2 anti-TCR clonotypic mAb conjugated with FITC. In a parallel set of experiments, B Long melanoma cells expressing a murine FcγRII (Weinshank et al., 1988) were incubated with 10 µg/ml purified DEF or 14-4-4 mAb as control (mouse IgG2a, ATCC) in the presence or absence of 2.4G-2 antiFcγRII mAb (Unkeless, 1979) , and then labeled with goat anti-γ2a-FITC. The percentage of positive cells was scored cytofluorimetrically among 5000 counting events. Complement-mediated cell cytotoxicity Purified T cells were incubated for 30 min at room temperature in Terasaki microtiter plates with various concentrations of DEF (50 ng to 2 µg), and the following controls: 14-4-4 mAb (mouse IgG2a anti-I-E d ) and 2G9 mAb (mouse IgG2a antihemagglutinin envelope protein of PR/8/A/34 influenza virus, Chemicon, Temecula, CA). Rabbit complement (Sigma Chemicals) was added for 45 min, cells were stained with eosine, and fixed with formaldehyde, according to a standard protocol (Thompson, 1981) . The percentage of lysed cells was determined microscopically using an inverted Zeiss microscope.
Cytokine assay
The production of IL-2 by the purified transgenic T cells or naive BALB/c spleen cells treated for 24 h with soluble DEF was assessed by using Cytoscreen mIL-2 ELISA kit (Biosource International, Camarillo, CA). Briefly, 2ϫ10 5 cells in RPMI complete medium were cultured for 24 h at 37°C polystyrene tubes coated with 50 µg/ml of DEF, BSA (negative control), 6.5.2 anti-TCR clonotypic mAb or F23 anti-TCR Vβ8 mAb. Cell culture supernatants were then incubated in microtiter strips coated with an antibody specific for mouse IL-2, and captured interleukins were revealed with biotinylated specific second antibodies. Streptavidin-peroxidase conjugate was used to develop the second antibody bound to the captured interleukins by microtiter strips coated with the first antibody, and the amount of enzyme was assessed colorimetrically at 450 nm in a Dynatech ELISA reader. The values obtained for triplicate samples were integrated against standard curves constructed with known amounts of mouse IL-2 standards, according to the manufacturer's instructions.
Results
We have generated a disulfide stabilized dimer of the CD4 T cell immunodominant epitope of HA of the A/PR/8/34 influenza virus, covalently linked to a murine I-E d -Ig chimeric molecule (DEF) (Figure 1 ). The gene fragments assembled in the HA110-120-I-Eβ d -Fcγ2a chimeric gene are shown in Figure 2 . Nucleotide sequencing showed that the gene fragment was assembled in frame and no mutations occurred during the process of genetic construction.
Structural integrity of DEF molecule
As illustrated in Figure 3a , the affinity purified DEF molecules eluted from the Superose-6 column as a 170 kDa molecule. This size indicated that the soluble DEF molecule was secreted by the SF9 infected cells as a homogeneous dimer. A minor degree of heterogeneity was revealed by anion exchange chromatography (Figure 3b ). It seems unlikely that the heterogeneity might be the result of proteolytic degradation. That is because first, the critical steps of proteolysis during the preparation of DEF molecules were avoided by using a cocktail of protease inhibitors, and second, DEF anion exchange chromatographic products showed identical electrophoretic patterns in SDS-PAGE (not shown). Most probably, the heterogeneity of DEF molecule was the result of different glycosylation by the insect cells.
SDS-PAGE under non-reducing/non-boiling conditions revealed a single band of 170 kDa (Figure 4a , lane 1) and under non-reducing/boiling conditions, two major bands of 110 and 30 kDa together with two minor bands of 55 and 80 kDa ( Figure 4a, lane 2) . The 170 kDa band corresponds to the molecular size of an intact HA110-120-I-E d αβ-Fcγ2a dimer, in agreement with the result obtained by size exclusion chromatography. The major bands of 110 and 30 kDa obtained after boiling DEF molecule in presence of detergent, correspond to the molecular size of a HA110-120-I-E d β-Fcγ2a dimer and to a single I-E d α chain, respectively. The minor bands of 55 and 80 kDa correspond to the molecular size of the HA110-120-I-E d β-Fcγ2a and HA110-120-I-E d αβ-Fcγ2a monomers, respectively. These monomers were generated under boiling conditions by dissociation of the dimeric DEF molecule. Under reducing and non-boiling conditions, DEF molecule migrated as three major bands of 50, 55 and 80 kDa which correspond to HA110-120-I-E d β-Fcγ2a and HA110-120-I-E d αβ-Fcγ2a monomers respectively, and a minor band of 30 kDa which corresponds to I-Eα chain (Figure 4a, lane 3) . Under reducing and boiling conditions, DEF molecule migrated as two bands of 50 and 55 kDa as well as 30 kDa, which correspond to the HA110-120-I-E d β-Fcγ2a monomer and I-Eα chain, respectively. The two bands of 50 and 55 kDa of the HA110-120-I-E d β-Fcγ2a (Figure 4a, lanes 3 and 4) may represent the two major forms of glycosylation as found by anion exchange chromatography.
Western blot analysis developed with goat anti-mouse γ2a Abs revealed also the 170 kDa band under non-reducing and non-boiling conditions, and two bands of 50 and 55 kDa under reducing and boiling conditions. This indicates that the dimeric DEF was correctly folded and preserved the antigenicity of the Fcγ2a fragment (Figure 4b, lanes 1 and 2) . Dimeric DEF molecule was also revealed under non-reducing and non-boiling conditions by 14-4-4 mAb, which recognizes a conformational epitope of I-E d α (Ozato et al., 1980) (Figure 4b, lane 3) , but not under reducing and boiling conditions (Figure 4b, lane 4) . Similar results on the antigenicity of DEF molecule were obtained in a 'sandwich' RIA using plates coated with goat anti-γ2a Abs and revealed with 125 I-goat anti-γ2a Abs or 125 I-14-4-4 mAb (not shown).
Binding of DEF molecule to the cognate TCR
We determined the ability of the HA110-120-I-E d complex of DEF chimeric molecule to bind to HA110-120-specific TCR. For this, we used either 14-3-1 TcH, or purified transgenic T cells expressing the 14.3d TCR which recognizes the HA110-120-I-E d complex. TcH were incubated with DEF molecules and then labeled with goat anti-γ2a-FITC. FACS analysis showed that 68% T cells were labeled by DEF (Figure 5b) . Similar results were obtained by incubation of TcH with the 6.5.2 anti-TCR clonotypic mAb specific for 14.3d TCR (not shown). The binding of DEF to the cognate TCR was inhibited to 3% by 6.5.2 mAb (Figure 5c ). This indicated that DEF bound specifically to the cognate TCRs. When T cells purified from transgenic mice were stained with DEF molecules, we detected 32% positive T cells. The same percentage was obtained by staining with 6.5.2 mAb-FITC conjugate (not shown).
Binding of DEF molecule to FcγR
To investigate the binding ability to FcγR of the Fcγ2a fragment expressed by DEF molecule, we used B Long melanoma cells transfected with the FcγRII receptor gene. Cells were incubated with either DEF molecules, or 14-4-4 mAb as positive control. Bound DEF or 14-4-4 mAb were revealed with goat anti-γ2a-FITC conjugate. Data depicted in Figure 5e and h show the binding of DEF molecule and 14-4-4 mAb to B Long cells respectively, as compared with the non-specific fluorescence in panels d and g, respectively. The binding of both DEF molecule and 14-4-4 mAb was inhibited by 2.4G-2 rat antiFcγRII mAb (Figure 5f and i, respectively). This indicated that DEF bound specifically to the cell surface exposed FcγRII. 
DEF complement-mediated cell cytotoxicity
The activation of complement cascade by IgG2a depends mainly on the structural integrity of the C1q binding site that is located on the hinge region and CH2-CH3 domains of the Fc fragment, particularly on the residues Glu318, Lys320, Lys322 and Pro331 (Reid, 1995) . To determine whether the folding of the Fcγ2a domains was preserved within DEF molecule, we measured the complement-mediated lysis induced by DEF molecule on purified T cells (85%) isolated from spleens of transgenic mice. It is known that initiation of the cascade reactions leading to complement activation requires two C1q binding sites in closed proximity of two Ig molecules. Cells treated with DEF in the presence of rabbit complement, and then stained with eosin, showed approximately 30% lysis. According to FACS analysis, a similar percentage (32%) of HA110-120-specific T cells was found after staining with 6.5.2 anti-TCR clonotypic mAb. The complement-mediated cytotoxicity by 14-4-4 mAb (IgG2a) was approximately 25%. The mouse IgG2a 2G9 induced below 5% lysis.
IL-2 production induced by DEF molecule
The biological effect of DEF molecule on the cognate T cells was monitored by the production of IL-2. As indicated in Figure 6 , transgenic cells treated with plastic immobilized DEF, 6.5.2 and F23 mAbs for 24 h in the absence of APCs, but not with immobilized BSA (control), secreted a significant amount of IL-2. In parallel experiments, IL-2 production was detected only from spleen cells purified from naive BALB/c mice incubated with plastic immobilized F23 mAb but not after incubation with DEF, 6.5.2 mAb or BSA. This suggests that interaction between plastic immobilized DEF molecules and specific TCR triggered early production of IL-2 in the peptide-specific T cells.
Discussion
The recombinant DEF molecule was secreted by the transfected SF9 insect cells as a 170 kDa soluble dimer. The dimer was Binding of DEF molecule (10 µg/ml) to 14-3-1 TcH (68%); (c) inhibition of binding of DEF molecule (10 µg/ml) to 14-3-1 TcH by 6.5.2 anti-TCR clonotypic mAb (100 µg/ml) (3%); (e) binding of DEF molecule (10 µg/ml) to B Long melanoma cells expressing FcγRII (52%), and (f) inhibition of binding of DEF molecule (10 µg/ml) to B Long cells by 2.4G-2 anti-FcγRII mAb (100 µg/ml) (2%). The 14-4-4 mAb (IgG2a) was used as positive control for binding to FcγRII, (h) 56%. The binding of 14-4-4 mAb (10 µg/ml) to B Long cells was inhibited to 5% by 2.4G-2 mAb (100 µg/ml) (i). stable in the presence of detergent (0.1% SDS), indicating that the covalently-linked HA110-120 peptide was correctly assembled in the groove of DEF molecule, being thus able to stabilize the MHC heterodimer. Indeed, it was previously shown that only the I-E d class II molecules loaded in vitro with peptide, but not the empty class-II molecules, migrate in SDS-PAGE under non-reducing/non-boiling conditions, as a single protein component (Germain et al., 1996) . DEF molecule preserved the antigenicity of both MHC and Fcγ2a fragments. This indicated that both extracellular domains of the I-E d α and I-E d β chains, as well as the Fcγ2a fragment, were assembled and folded correctly. As a result, the MHCpeptide portion of DEF molecule bound to a cognate TCR expressed either on a TcH, or on transgenic T cells. Although at present we have no direct evidence that the dimeric DEF molecule cross-links the peptide specific TCRs, it is likely that this interaction may well happen. First, our results in complement-mediated lysis assay indicated that the flexibility of hinge region and CH1-CH2 domains, which assemble the C1q complement binding site, was preserved. DEF was able to mediate complement cytotoxicity after binding to HA110-120 transgenic TCRs. The same extent of flexibility of these domains may also favor the accommodation of the longitudinal axes of 'two-arm' I-E d -HA peptide complexes of DEF to simultaneously interact with two TCRs on the surface of a (2ϫ10 5 ) were incubated for 24 h in polystyrene tubes coated with 50 µg/ml BSA, F23 mAb (anti-TCR Vβ8), 6.5.2 anti-TCR clonotypic mAb, or DEF, in the absence of APCs. The production of IL-2 was determined in the cell culture supernatants by ELISA, as described in Material and methods. The pg/ml values represent the mean of triplicate wells. Variation between triplicates was between Ϯ2.7 to Ϯ4.2 pg/ml. single T cell. Thus, our FACS analysis indicated the same percentage of TCR-HA transgenic cells was revealed by staining with DEF as by 6.5.2 anti-TCR clonotypic mAb (32%). This indicated that DEF molecules exhibit at least the same affinity binding to 14.3d transgenic TCR as the anticlonotypic mAb. Most likely, the binding occurred as single T cell-DEF interaction, because only single T cells were windowed by FACS analysis. According to Weber et al. (1992) , binding assays between the monomeric 14.3d transgenic TCR and I-E d -HA peptide complexes have failed so far. In addition, studies of Altman et al. (1996) demonstrated that only the interaction between multimerized MHC-peptide complexes and cognate TCRs, but not between the monomeric ones, was detected by FACS analysis. Secondly, Reich et al. (1997) demonstrated that a recombinant dimer of murine I-E k -peptide complexes connected through a flexible linker between the peptides, showed significantly higher affinity for the cognate TCRs than did the monomer. Their studies suggest that the degree of affinity binding between MHC class II-peptide complexes and TCRs dictates the intensity of T cell signaling pathways of interleukin secretion (Reich et al., 1997) . Indeed, our cytokine assays indicated that, for the same percentage of staining TCR-HA transgenic T cells with DEF versus 6.5.2 mAb by FACS (32%), DEF molecules induced almost twice as much IL-2 from the transgenic cells than 6.5.2 mAb did. In aggregate, our results along with others suggest that crosslinking of the cognate TCRs by DEF molecules is likely to take place. Further crystallographic studies would be necessary to confirm our supposition.
Like plastic immobilized 6.5.2 anti-TCR clonotypic and F.23 anti-TCR Vβ8 mAbs, DEF molecule immobilized on the plastic surface was able to induce early IL-2 production from cognate T cells isolated from transgenic mice, in the absence of APCs. Naive BALB/c spleen cells incubated with plastic immobilized F23 mAb, but not those incubated with plastic immobilized DEF or 6.5.2 mAb, secreted IL-2. This indicates that only a cognate interaction between DEF and TCRs could trigger early events of signal transduction in T cells. Obviously, further investigations will be required to establish the extent of immunomodulatory effects induced by DEF on the cellular and humoral immune responses.
The strategy of designing stable dimeric forms of MHC class II antigen presenting molecules which are able to crosslink TCRs on the cognate T cells, to mediate complement cytotoxicity, and to trigger early stimulation events in cognate T cells may represent a novel platform for the development of prodrugs endowed with T cell immunomodulatory effects.
